381 SUPLEXA, a multimodal autologous cellular therapy, shows immunomodulatory behavior in cancer patients consistent with improved anti-tumor immune function

• Rohit Joshi,
• Sharron Gargosky,
• Ganessan Kichenadasse,
• James A Lederer,
• Jeffrey Goh,
• Frank Borriello,
• John F Pulford,
• Ekaterina Murzin,
• Daniel Younger

Affiliations

Rohit Joshi

8Cancer Research SA, Adelaide, Australia

Sharron Gargosky

Aff1 PrimaBioMed United States

Ganessan Kichenadasse

11Flinders Medical Centre, Medical Oncology, Bedford Park, Australia

James A Lederer

8 Department of Surgery, Brigham and Women`s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Jeffrey Goh

15 Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia

Frank Borriello

4Alloplex Biotherapeutics Inc, Woburn, MA, USA

John F Pulford

1Brigham and Women’s Hospital, Boston, MA, USA

Ekaterina Murzin

1Brigham and Women’s Hospital, Boston, MA, USA

Daniel Younger

1Brigham and Women’s Hospital, Boston, MA, USA